Login / Signup

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial.

Luís PuigAndrey L BakulevMuza M KokhanAlexey V SamtsovVladislav R KhairutdinovMaria A MorozovaNikita A ZolkinIvan V KuryshevAlexey N PetrovAntonina V ArtemevaArina V Zinkina-Orikhan
Published in: Dermatology and therapy (2021)
The trial is registered at the US National Institutes of Health (ClinicalTrials.gov; NCT03390101).
Keyphrases